MPs Erlend Svardal Bøe and Margret Hagerup propose measures to strengthen Norway's vaccination system. The proposers argue that Norway lags behind comparable countries in adopting new vaccines and lacks a mechanism to automatically incorporate vaccines recommended by the Medicines Agency and the Public Health Institute. They call for authorization thresholds for vaccines, expanded pharmacy-based vaccination services, transparent processing timelines, and incentives for municipalities to increase vaccination rates.
AI-generated summary · Model: Claude Haiku 4.5 · Generated: 14 May 2026
These are the proposals in the document, not decisions. See the votes for the outcome.
The Storting calls on the government to ensure that vaccines recommended by the Medicines Agency and the Public Health Institute are automatically incorporated into national vaccination programmes.
The Storting calls on the government to report back on how this can be achieved in connection with the 2027 budget.
The Storting calls on the government to consider establishing an authorization threshold for vaccines in vaccination programmes and in the blue prescription scheme, allowing the Medicines Agency to approve reimbursement for vaccines below a specified cost limit. The Storting calls on the government to report back to the Storting in an appropriate manner.
The Storting calls on the government to expand the automatic reminder system to cover all residents. The automatic reminder system should notify individuals when booster vaccines or other necessary vaccines included in the adult vaccination programme are due. This service could be organized as part of helsenorge.no, and individuals should have the option to opt out.
The Storting calls on the government to introduce transparent timelines for vaccine assessment, comparable to those applied to other medicines, including processing times from submission of a notice of intended use to inclusion in the vaccination programme.
The Storting calls on the government to facilitate increased vaccination services in pharmacies and vaccination clinics, including expanded prescribing rights for pharmacists and other healthcare personnel, and greater discretion for pharmacies to actively inform patients about recommended vaccines.
The Storting calls on the government to ensure that vaccines can be offered to larger patient groups on blue prescription before the next infection season, consistent with the Storting's position in its review of the Priorities Report in spring 2025, cf. Committee Recommendation 461 S (2024–2025).